50 results
Page 2 of 3
424B5
vly5vru5r6b pxpw
12 Mar 20
Prospectus supplement for primary offering
12:00am
424B5
fsjg66q
10 Mar 20
Prospectus supplement for primary offering
9:26pm
8-K
ehssy9phl7utv02t9t8
13 Jan 20
Results of Operations and Financial Condition
7:30am
8-K
yj940lrlxb k3dkf9k8
7 Jan 19
Regulation FD Disclosure
7:00am
8-K
EX-99.1
duatu2flg wa5
8 Nov 18
Kala Pharmaceuticals Reports Third Quarter 2018 Financial Results
4:05pm
8-K
EX-1.1
n2zjwrygr lj
5 Oct 18
Kala Pharmaceuticals Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock
6:01am
424B2
n25rrjtin4d0y
3 Oct 18
Prospectus for primary offering
5:26pm
424B2
vl30h9tenn5f
2 Oct 18
Prospectus for primary offering
5:26pm